CME Group (CME) Stock Forecast & Price Target $267.04 -4.24 (-1.56%) Closing price 03:58 PM EasternExtended Trading$266.30 -0.74 (-0.28%) As of 04:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CME Group - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating HoldBased on 16 Analyst RatingsSell2Hold7Buy7 Based on 16 Wall Street analysts who have issued ratings for CME Group in the last 12 months, the stock has a consensus rating of "Hold." Out of the 16 analysts, 2 have given a sell rating, 7 have given a hold rating, and 7 have given a buy rating for CME. Consensus Price Target $283.716.24% Upside According to the 16 analysts' twelve-month price targets for CME Group, the average price target is $283.71. The highest price target for CME is $312.00, while the lowest price target for CME is $219.00. The average price target represents a forecasted upside of 6.24% from the current price of $267.04. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for CME and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CME Group and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CME Analyst Ratings Over TimeTypeCurrent Forecast10/14/24 to 10/14/251 Month Ago9/14/24 to 9/14/253 Months Ago7/16/24 to 7/16/251 Year Ago10/15/23 to 10/14/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy7 Buy rating(s)4 Buy rating(s)5 Buy rating(s)4 Buy rating(s)Hold7 Hold rating(s)9 Hold rating(s)8 Hold rating(s)7 Hold rating(s)Sell2 Sell rating(s)3 Sell rating(s)3 Sell rating(s)4 Sell rating(s)Consensus Price Target$283.71$260.60$261.80$219.53Forecasted Upside6.24% Upside-0.65% Downside-5.67% Downside-2.08% DownsideConsensus RatingHoldHoldHoldHold CME Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History CME Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table CME Group Stock vs. The CompetitionTypeCME GroupFinance CompaniesS&P 500Consensus Rating Score 2.31 2.31 2.52Consensus RatingHoldHoldModerate BuyPredicted Upside5.07% Upside22.44% Upside12.93% UpsideNews Sentiment RatingPositive NewsSee Recent CME NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails10/14/2025JPMorgan Chase & Co.2 of 5 starsKenneth Worthington Not RatedBoost TargetUnderweight$252.00 ➝ $256.00-5.63%10/13/2025Raymond James Financial4 of 5 starsPatrick O'Shaughnessy2 of 5 starsLower TargetOutperform$309.00 ➝ $307.00+13.10%10/13/2025Keefe, Bruyette & Woods5 of 5 stars Boost TargetMarket Perform$283.00 ➝ $287.00+5.73%10/10/2025Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetBuy$313.00 ➝ $304.00+13.08%10/9/2025Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetHold$276.00 ➝ $266.00+0.40%10/8/2025BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBenjamin BudishSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetEqual Weight$298.00 ➝ $280.00+6.22%10/8/2025TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost TargetHold$281.00 ➝ $288.00+8.70%10/8/2025Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingBuy (B)10/1/2025Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingPatrick MoleySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOverweight$303.00 ➝ $312.00+17.37%9/25/2025CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingChristopher AllenSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeNeutral ➝ Buy$275.00 ➝ $300.00+13.45% Get the Latest News and Ratings for CME and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter. 9/8/2025UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAlex KrammSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetNeutral$305.00 ➝ $285.00+8.80%7/24/2025OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingOwen LauSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOutperform$300.00 ➝ $303.00+9.30%7/15/2025Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingPatrick MoleySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOverweight$283.00 ➝ $296.00+8.10%5/24/2025Erste Group BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingH. EngelSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/3/2025Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAshish SabadraSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingSector Perform$269.00 ➝ $269.00-0.64%4/2/2025Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingCraig SiegenthalerSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetUnderperform$200.00 ➝ $219.00-16.64%10/8/2024Redburn AtlanticSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingS. ClinchSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeBuy ➝ Neutral$244.00+10.04%10/3/2024The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost TargetSell$195.00 ➝ $198.00-11.89%4/25/2024Rosenblatt SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingSell$185.00 ➝ $187.00-12.04%3/6/2024ArgusSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost TargetBuy$225.00 ➝ $245.00+12.27%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 04:09 PM ET. Should I Buy CME Group Stock? CME Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, October 13, 2025. Please send any questions or comments about these CME Group pros and cons to contact@marketbeat.com. CME Group Bull Case Here are some ways that investors could benefit from investing in CME Group Inc.: The current stock price is around $271.45, which may present a buying opportunity for investors looking for potential growth. Recent analyst ratings show a consensus rating of "Hold" with several analysts issuing "Buy" ratings, indicating confidence in the company's future performance. CME Group Inc. has a strong market capitalization of approximately $97.83 billion, suggesting stability and a solid position in the financial services sector. Insider trading activity indicates that insiders have sold shares recently, but they still hold a significant portion of the stock, which can be a sign of confidence in the company's prospects. Hedge funds and institutional investors own about 87.75% of the stock, reflecting strong institutional interest and confidence in CME Group Inc.'s business model. CME Group Bear Case Investors should be bearish about investing in CME Group Inc. for these reasons: Insider sales totaled 13,043 shares worth over $3.5 million in the last three months, which could raise concerns about the company's short-term outlook. Several analysts have recently lowered their price targets for CME Group Inc., indicating potential challenges ahead in achieving previous growth expectations. The company has a relatively high price-to-earnings ratio of 26.28, which may suggest that the stock is overvalued compared to its earnings potential. With a beta of 0.41, the stock is less volatile than the market, which may limit potential gains during bullish market conditions. Recent price adjustments by analysts, including reductions from firms like Jefferies and Deutsche Bank, may indicate a cautious sentiment towards the stock's future performance. CME Forecast - Frequently Asked Questions What is CME Group's forecast for 2025? According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for CME Group is $283.71, with a high forecast of $312.00 and a low forecast of $219.00. Should I buy or sell CME Group stock right now? 16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 2 sell ratings, 7 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CME shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares. Does CME Group's stock price have much upside? According to analysts, CME Group's stock has a predicted upside of 6.24% based on their 12-month stock forecasts. Has CME Group been upgraded by Wall Street analysts recently? Over the previous 90 days, CME Group's stock had 1 upgrade by analysts. What analysts cover CME Group? CME Group has been rated by research analysts at Barclays, Citigroup, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, Oppenheimer, Raymond James Financial, TD Cowen, UBS Group, and Weiss Ratings in the past 90 days. Do Wall Street analysts like CME Group more than its competitors? Analysts like CME Group more than other "finance" companies. The consensus rating score for CME Group is 2.31 while the average consensus rating score for "finance" companies is 2.31. Learn more on how CME compares to other companies. Stock Forecasts and Research Tools Related Companies Cboe Global Markets Stock Forecast Coinbase Global Stock Forecast MarketAxess Stock Forecast Nasdaq Stock Forecast NVIDIA Stock Forecast Interactive Brokers Group Stock Forecast Intercontinental Exchange Stock Forecast Moody's Stock Forecast MSCI Stock Forecast Arrow Financial Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:CME) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredWhy Wall Street is piling into the “Debasement Trade”Wall Street is piling into what insiders are calling the “Debasement Trade” — and according to former Goldman ...Stansberry Research | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CME Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CME Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
